Ivania Rizo MD

Assistant Professor, Endocrinology, Diabetes, Nutrition & Weight Management

720 Harrison Ave | (617) 638-8638
ivamrizo@bu.edu
ivania.rizo@bmc.org

Sections

Endocrinology, Diabetes, Nutrition & Weight Management

Biography

Ivania Rizo, MD, is dedicated to advancing excellence in diabetes, obesity, and health equity. She serves as Director of Obesity Medicine, Co-Medical Director, and Assistant Professor in the Section of Endocrinology, Diabetes, Nutrition & Weight Management at the Boston University Chobanian & Avedisian School of Medicine. In addition, Dr. Rizo is the Diabetes Clinical Co-Lead for Boston Medical Center’s (BMC) Health Equity Accelerator and the Endocrine Lead for Heart of Communities, a multisector partnership between BMC, Mass General Brigham, and Mattapan Community Health Center.

Dr. Rizo earned her medical degree from Georgetown University School of Medicine, completed her Internal Medicine residency at Georgetown University, and completed her Endocrinology fellowship at the University of Alabama at Birmingham (UAB). She subsequently joined the UAB faculty as an Assistant Professor and Staff Physician at the Kirkland Clinic before being recruited to her current role at BMC. She is triple board-certified in Internal Medicine, Endocrinology, and Obesity Medicine.

Her clinical and academic interests include obesity, diabetes, and cardiovascular–kidney–metabolic disease. As Diabetes Clinical Co-Lead for BMC’s Health Equity Accelerator, Dr. Rizo develops programs aimed at expanding equitable access to high-quality diabetes and obesity care—advancing BMC’s mission of providing exceptional care without exception.

Dr. Rizo is an active member of the Endocrine Society, the American Diabetes Association, and The Obesity Society.

Websites

BU Profile

Boston Medical Center Provider Profile

Education

Physiology, MD, Georgetown University

Physiology, BS, University of Maryland

Publications

Published on 6/6/2025

Campos A, Fantasia KL, Rizo I. Knowledge, attitudes, and practices in obesity among trained and in-training primary care providers in an urban safety-net hospital system. Obes Pillars. 2025 Sep; 15:100185. PMID: 40546447.

PubMed

Published on 4/25/2025

Mohanty A, Austad K, Bosch NA, Long MT, Nolen-Doerr E, Walkey AJ, Drainoni ML, Rizo I, Fantasia KL. Assessing Clinician Engagement With a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic. Endocr Pract. 2025 Jul; 31(7):899-905. PMID: 40288606.

PubMed

Published on 8/15/2022

Ryan TJ, Heyman AS, Mulvey EN, McLaughlin A, Rizo IM, Assoumou SA. Factors associated with inpatient complications among patients with obesity and COVID-19 at an urban safety-net hospital: A retrospective cohort study. Obes Sci Pract. 2022 Aug 15; 8(6):794-800. PMID: 35938065.

PubMed

Published on 3/10/2021

Fantasia KL, Wirunsawanya K, Lee C, Rizo I. Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital. J Diabetes Sci Technol. 2021 09; 15(5):1010-1017. PMID: 33719610.

PubMed

Published on 9/1/2019

Nolen-Doerr E, Stockman MC, Rizo I. Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity. Curr Obes Rep. 2019 Sep; 8(3):284-291. PMID: 31124035.

PubMed

Published on 6/7/2019

Dupepe E, Patel D, Miller J, Rizo I, Vaughan TB, Riley K. Postoperative day 1 versus postoperative day 5 morning cortisol for predicting an intact hypothalamic-pituitary axis: A cohort analysis. Surg Neurol Int. 2019; 10:91. PMID: 31528429.

PubMed

Published on 1/15/2019

Rizo IM, Apovian CM. Diabetic Ketoacidosis Post Bariatric Surgery. Front Endocrinol (Lausanne). 2018; 9:812. PMID: 30697192.

PubMed

Published on 6/29/2018

Rodriguez-Diaz E, Rizo I, Sullivan C, Steenkamp DW. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity. J Diabetes Sci Technol. 2018 11; 12(6):1239-1240. PMID: 29957042.

PubMed

Published on 8/1/2002

Hotez PJ, Ashcom J, Bin Z, Bethony J, Williamson A, Hawdon JM, Jianjun F, Dobardzic A, Rizo I, Bolden J, Jin Q, Yan W, Dobardzic R, Chung-Debose S, Crowell M, Datu B, Delaney A, Dragonovski D, Jiang Y, Yueyuan L, Ghosh K, Loukas A, Brandt W, Russell PK, Zook BC. Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol. 2002 Aug; 88(4):684-90. PMID: 12197114.

PubMed

Published on 12/8/2000

Mantey SA, Coy DH, Pradhan TK, Igarashi H, Rizo IM, Shen L, Hou W, Hocart SJ, Jensen RT. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3. J Biol Chem. 2001 Mar 23; 276(12):9219-29. PMID: 11112777.

PubMed

View full list of 10 publications.